Today, AI and Medical Technology Company Echo IQ Limited (ASX: EIQ) revealed important leadership changes to aid its commercial expansion. Matthew Dodds is the new Chief Financial Officer, starting on June 24, 2026. Additionally, Dr. Vinod Thourani, a notable figure in heart disease, heart valve treatments, and cardiovascular surgery, has joined as a Clinical Advisor. These appointments aim to boost growth of the EchoSolv platform, increase presence in the U.S. healthcare sector, and advance regulatory efforts with the U.S. FDA.